Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease - Wikidata - awgldk - TriplyDB

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

http://www.wikidata.org/entity/Q37398634

about

Current neuroimaging techniques in Alzheimer's disease and applications in animal models Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice Magnetic resonance spectroscopy in common dementias Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.Clinical proton MR spectroscopy in central nervous system disorders Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex.The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study Regional myo-inositol concentration in mild cognitive impairment Using 1H magnetic resonance spectroscopic imaging.Mild cognitive impairment: ten years later.MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease Brain metabolic correlates of decision making in amnestic mild cognitive impairment.Fetal and neonatal iron deficiency causes volume loss and alters the neurochemical profile of the adult rat hippocampus Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.Proton spectroscopic imaging of brain metabolites in basal ganglia of healthy older adults APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T.Iron supplementation dose for perinatal iron deficiency differentially alters the neurochemistry of the frontal cortex and hippocampus in adult rats.Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?1H magnetic resonance spectroscopy in dementia.Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.Neurochemical and Neuroanatomical Plasticity Following Memory Training and Yoga Interventions in Older Adults with Mild Cognitive Impairment.APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.Neuroimaging studies in Alzheimer's disease. A review.Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Advances in Neuroimaging for Neurodegenerative Disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease.

P2860

Q30576714-81438B0F-5DD4-4CAE-91BD-2705D54C843B Q30606675-9D7174C3-AE13-4AAD-BA9B-6C899723BFFF Q30630699-5CC5D4BD-924A-4763-BF69-DEB2F6CB4821 Q30635401-C9843C0E-A840-458D-B7B6-B1BC89C54415 Q30660402-B10051AE-54C3-4AD6-A0D4-E83498155EDB Q30758233-323B0C20-18A1-4A7F-83C4-5071B006C0D2 Q30764446-547831BC-5490-4C5F-B884-FCA55E79FFB6 Q30841801-8A1BF71C-BBF1-40FB-BAFA-38FAE3C232BD Q30996805-A9F3B96D-47C4-47E8-BC3E-DCECC5446642 Q31026422-4D8F46D0-7C8E-48FB-834A-5E14B83599FC Q31159878-28091C51-638D-412B-9EAA-906F4CD26EAD Q33716031-CFEDFE13-7C57-4502-998A-023940E21156 Q33875000-6109DD13-DC56-4833-8792-C5CB82D31280 Q34152954-05A7976F-EE6B-4A5D-893E-1CC16549D9E0 Q34247831-E628DEC3-33DE-4A4F-9660-0CE66B04E68F Q34576451-6C2AEA11-BCC3-479B-968A-75BC5739DD59 Q34847370-DFFE5EDD-1A9D-4A0A-B76E-B3F0170505C9 Q34964670-08DBB4D1-0514-414C-B6FC-F801F4169F09 Q35097548-167499C4-8326-4B2D-A8E8-EF23DD2F6F62 Q35205644-0184068D-3E31-49D8-A978-46BEDA12D37F Q35210272-42CBB2CF-7BE2-4C5E-837C-69A345B9CD7A Q35653958-F90CB2C4-7C08-427B-AB2A-5A5DED027DA9 Q36083501-DA58AF25-A804-4FCE-99DD-8FE26729A0C5 Q36364569-96268179-CD9C-4278-A328-433256D6A713 Q36584697-34897C7A-4677-40FE-AFD0-A2DDA2AB5901 Q37073878-DF167A93-E434-47EE-BF6D-BE36BEDD33EB Q37086701-611134DE-701B-4648-9048-1F0E753BD014 Q37118083-8E352966-3672-4169-9B16-503BE6F92233 Q37150637-B76D050C-E5CC-4454-A250-145A5D5350E9 Q37191378-1BB71AEC-AB43-489D-8AF1-BF2B2784AF72 Q37254543-54539E08-F93B-4362-A299-0B0673DE5CB1 Q37424431-9D42C961-281C-4BF1-B5F4-8ACEAC9CA310 Q37459037-3E4FD541-C690-43DF-8794-DB615BBE5CF7 Q38084188-BED680F5-8683-4DB0-8E1A-A88F3EF7BA6B Q38161007-7A7DCD82-5F04-4647-8AAF-D4433C90CCA7 Q38190687-63C87B69-D7B5-4B6F-B1A9-9872EA5D93DD Q38663083-312BE2D3-2482-4742-9842-F35D89FBB458 Q38693438-3C8B1895-8BEB-41EC-B927-44772024E379 Q38962796-DD460278-BEE3-477F-A594-E0DD7C819C6B Q42103589-094AD5CE-BD9C-4495-B00C-E1C1CC53CCE4

P2860

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

http://www.wikidata.org/entity/Q37398634

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 July 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

@en

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.

@nl

type

label

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

@en

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.

@nl

prefLabel

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

@en

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.

@nl

P1433

Q37398634-78F8258A-75FE-4D10-B122-FA52EEF7EFBB

P1476

Q37398634-3AC95B8D-FD67-486C-84FD-33F4C9EC9BDB

P2093

Q37398634-004355F4-A816-4CA6-B821-7F76D9AEAF79

Q37398634-086D11B3-FD06-4426-9A11-4F66EAEAE166

Q37398634-1670794B-D13F-492E-91C1-1235E3347948

Q37398634-384628CB-9A77-4AC2-865A-CB81C07AB34D

Q37398634-541EBD81-4CCA-4891-B459-3ECE9E6BF638

Q37398634-678A296F-1513-4668-A6AB-E4C9B22CAD55

Q37398634-B1FA1047-3361-455D-B93A-C5945307F875

Q37398634-B5F04CAB-8465-46C5-97B3-7F7CD0B0FE3B

P2860

Q37398634-0B13608C-A18C-415F-827A-511512F833F2

Q37398634-0CA0185E-8D3A-456E-B489-84D2C6124FF5

Q37398634-0CC5EA0D-A188-4EBF-B8A6-43F317A7F1D3

Q37398634-0DDED3DB-4327-456B-92E2-FCE411417F6F

Q37398634-0F141919-8C6F-468B-B2DD-EF2877125623

Q37398634-126F2791-A420-4FA6-8177-9E7134F9AEBE

Q37398634-15989785-A1CF-4AFC-9A7F-4812B650CFD2

Q37398634-17586F89-AE45-4FE4-B41D-147A25493FCE

Q37398634-17DB632A-B14D-4FA6-B416-E27A348D6AFE

Q37398634-1AD536A2-17DD-4E58-A6EB-81A1C8EB378C

P304

Q37398634-8DDF2CEB-A13D-45BE-998A-5946EE12C63C

P31

Q37398634-42E40011-23F2-4D51-972C-D05F8C606E20

P356

Q37398634-DC7520A5-2812-4966-82A6-DCE85D2715B8

P407

Q37398634-007F654C-F905-46D2-B08D-5D5BE5753BFA

P433

Q37398634-E99006B6-9F1D-43CF-A8BB-0D5965AD6506

P478

Q37398634-48C6F092-103C-45C8-AA97-B8D32FF6C5C8

P50

Q37398634-0B763170-BE3D-416C-BEE9-518CDA4FB46F

Q37398634-5074E3F3-DBCD-4119-A635-132D40C5A302

Q37398634-61386717-9FC9-46F8-8DB4-2BB66362CA0B

Q37398634-68D7704E-22D7-4988-853C-25F3782857AB

Q37398634-B86497EB-8C16-4EDF-B640-68198FD22DEE

P577

Q37398634-F3BDC758-9E64-4EED-8D1B-71D73770D821

P5875

Q37398634-C3BB1F2C-D78E-4E17-8801-93B2FE2F8BD4

P698

Q37398634-ADB945A9-8470-4626-B66C-2A0018FB1C0D

P921

Q37398634-77340B13-BB43-47BD-9CE3-CE950FB40C3B

P932

Q37398634-0388C1C6-0451-4148-81FF-FA68A304602F

P356

J.NEUROBIOLAGING.2006.06.018

P1433

Neurobiology of Aging

P1476

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Denise Reyes

http://www.w3.org/2001/XMLSchema#string

Eric G Tangalos

http://www.w3.org/2001/XMLSchema#string

Jeffrey Gunter

http://www.w3.org/2001/XMLSchema#string

Maria Shiung

http://www.w3.org/2001/XMLSchema#string

Peter C O'Brien

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

What's wrong with Bonferroni adjustments.

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.

Magnetic resonance spectroscopy in AD.

Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects.

Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Current concepts in mild cognitive impairment.

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

P304

1330-1339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2006.06.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2006-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6926503

http://www.w3.org/2001/XMLSchema#string

P698

16860440

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2766807

http://www.w3.org/2001/XMLSchema#string